Increasing the Coverage of Severe Acute Malnutrition (SAM) Treatment in Ethiopia (R-SWITCH)

Effect of Leveraging Community-level Structures to Strengthen Prevention, Screening and Treatment of Severe Acute Malnutrition in Ethiopia

The R-SWITCH intervention aims to address the low coverage of treatment for severe wasting (SAM) by leveraging existing community groups to deliver an integrated package focused on prevention, screening, referral, and treatment of SAM. It includes behavior change communication on child nutrition and health, active screening, improved passive screening at health posts, and follow-up of referred cases and those enrolled in outpatient treatment programs (OTP). The primary objectives of the R-SWITCH studies are to assess the intervention's impact on OTP coverage, identify implementation barriers and facilitators, and evaluate its cost-efficiency and cost-effectiveness.

Study Overview

Detailed Description

Despite the high mortality risk of severe wasting (also referred to as severe acute malnutrition or SAM), only a small proportion of children with severe wasting are currently identified and admitted to available outpatient treatment programs (OTP). In 2020, an estimated 4.9 million children with severe wasting received treatment, approximately a third of the total burden. Outside of humanitarian settings, this proportion is even lower (estimated to be around 15%). These figures highlight the urgent need to increase treatment coverage to meet the Sustainable Development Goals (SDG), which aim to reduce the prevalence of child wasting to less than 5% by 2025 and less than 3% by 2030. The continuum of care for SAM, from case identification, referral to treatment, and post-treatment follow-up, is hampered by several barriers including caregiver lack of awareness on the risks and treatment services of SAM, stigma related to SAM, poor accessibility to treatment, frequent stockouts of treatment inputs, and the overall workload faced by first-line health workers.

The R-SWITCH intervention will leverage existing community groups to deliver an integrated package aimed at preventing SAM through behavior change communication (BCC) on child nutrition and health, increasing wasting screening coverage through active screening, family-led MUAC and improved passive screening health posts, increasing treatment coverage through follow-up of earlier referred cases, cases enrolled in OTP, and children who completed OTP and recovered.

The primary objectives of the R-SWITCH studies are:

  • To assess the impact of the R-SWITCH intervention on SAM OTP coverage
  • To identify implementation barriers and facilitators
  • To assess the cost-efficiency and cost-effectiveness of the intervention package and services

Study Type

Interventional

Enrollment (Estimated)

1080

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Jimma, Ethiopia
        • Recruiting
        • Kersa and Jeldessa woredas
        • Principal Investigator:
          • Lieven Huybregts, PhD
        • Principal Investigator:
          • Tefera Belachew, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Child 6-59 months of age
  • Suffering from SAM (defined as MUAC < 115mm or presence of bilateral pitting edema or Weight-for-Length Z-score <-3) OR currently enrolled in SAM OTP

Exclusion Criteria:

- Anthropometric malformation or being handicapped which hampers anthropometric measurements.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard of Care
  • Usual screening of wasting by health extension workers (HEW) using MUAC
  • Previous introduction of Family-led MUAC (not maintained)
  • Behavior Change Communication (BCC) offered by Health extension worker (low intensity)
  • Treatment of SAM at health post or health center
  • Follow-up of SAM OTP defaults through home visits by HEW (very low intensity)
Experimental: R-SWITCH integrated intervention package
  1. Monthly group meetings of AFD community groups
  2. Introduction of weight-for-age Z-score <-3 as an additional screening criterion
  3. Promotion of Family-led MUAC screening and SAM awareness to fathers, community and religious leaders
  4. Follow-up and counselling during home visits by AFD leaders
  5. Strengthening communication between HEW and AFDs
  1. Monthly group meetings of Alliance for Development (AFD) community groups) and their members (caregivers of children 0-59 months of age):

    • Introduction and refresher of Family-led MUAC
    • Active screening of wasting by AFD
    • Group SBCC on Infant and Young Child Feeding (IYCF), health and Water, Sanitation and Hygiene (WaSH) with a focus on SAM
    • Promotion of health services such as GMP
  2. Introduction of weight-for-age Z-score <-3 as screening criterion for passive screening by health extension workers at any contact with children (e.g. during GMP)
  3. Promotion of Family-led MUAC screening and SAM awareness to fathers during male agricultural/pastoralist extension activities and by community and religious leaders (creating social support)
  4. Follow-up and counselling during home visits by AFD leaders of i) earlier referred cases of SAM, ii) cases enrolled in SAM OTP, iii) and recovered SAM cases discharged from OTP
  5. Strengthening communication between HEW and AFDs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Period prevalence of SAM OTP treatment coverage in children 6-59 months of age
Time Frame: After 24 months of program implementation

Defined as the proportion of children with Severe Acute Malnutrition (SAM) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment".

  • SAM is defined as a Mid-Upper Arm Circumference <115mm or a weight-for-height Z-score <-3 (relative to the World Health Organization (WHO) 2006 growth standards) or presence of bilateral pitting edema.
  • "Under treatment" is defined as:

    • the caregiver acknowledging the child is enrolled in a SAM OTP AND
    • the child was fed ready-to-use therapeutic food (RUTF) over the last three days AND
    • the caregiver can either show at least one full RUTF sachet OR more than one empty RUTF sachet.
After 24 months of program implementation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Point prevalence of SAM OTP treatment coverage in children 6-59 months of age
Time Frame: After 24 months of program implementation
Defined as the proportion of children with SAM at the time of the survey that are under treatment (see definition under primary outcome
After 24 months of program implementation
Period prevalence of SAM OTP treatment coverage in the subgroup of treatment eligible children 6-59 months of age
Time Frame: After 24 months of program implementation

Defined as the proportion of children with Severe Acute Malnutrition (SAM) or Severe underweight (weight-for-age Z-score <-3) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment".

  • SAM is defined as a Mid-Upper Arm Circumference <115mm or a weight-for-height Z-score <-3 (relative to the WHO 2006 growth standards) or presence of bilateral pitting edema.
  • "Under treatment" is defined as:

    • the caregiver acknowledging the child is enrolled in a SAM OTP AND
    • the child was fed ready-to-use therapeutic food (RUTF) over the last three days AND
    • the caregiver can either show at least one full RUTF sachet OR more than one empty RUTF sachet.
After 24 months of program implementation
Screening coverage of SAM
Time Frame: After 24 months of program implementation
Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver)
After 24 months of program implementation
Screening coverage of severe underweight
Time Frame: After 24 months of program implementation
Defined as the proportion of children aged 6-59 months with severe underweight (weight-for-age Z-score <-3 relative to WHO 2006 growth standard) screened over the last 30 days (as reported by the caregiver)
After 24 months of program implementation
Platform specific screening coverage of SAM
Time Frame: After 24 months of program implementation

Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver):

  • by Family-led MUAC ( screening by family members using a MUAC tape)
  • during growth monitor promotion (GMP) consultations
  • during Integrated management of childhood illness consultations
After 24 months of program implementation
Growth Monitoring Promotion (GMP) consultation attendance
Time Frame: After 24 months of program implementation
Defined as the proportion of children aged 6-59 months with SAM that attended GMP over the last 30 days (as reported by the caregiver).
After 24 months of program implementation
AFD group meeting attendance
Time Frame: After 24 months of program implementation
Defined as the proportion of of children aged 6-59 months with SAM that attended the monthly AFD group contact over the last 30 days (as reported by the caregiver).
After 24 months of program implementation
AFD home visit coverage
Time Frame: After 24 months of program implementation
Defined as the proportion of children aged 6-59 months with SAM and children enrolled in SAM OTP that received a home visit by an AFD leader/member over the last 30 days (as reported by the caregiver).
After 24 months of program implementation
Prevalence of SAM
Time Frame: After 24 months of program implementation
Defined as the proportion of children aged 6-59 months with SAM (defined as WHZ <-3 or a MUAC < 115 mm or the presence of bilateral pitting edema). To calculate WHZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Prevalence of wasting
Time Frame: After 24 months of program implementation
Defined as the proportion of children aged 6-59 months with wasting (defined as WHZ <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema). To calculate WHZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Prevalence of stunting
Time Frame: After 24 months of program implementation
Defined as the proportion of children aged 6-59 months with stunting (defined as height-for-age Z-scores (HAZ) <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema). To calculate HAZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Prevalence of underweight and severe underweight
Time Frame: After 24 months of program implementation
Defined as the proportion of children aged 6-59 months with underweight (defined as weight-for-age Z-scores (WAZ) <-2 ) and severe underweight (defined as WAZ <-3 ). To calculate WAZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Mean height-for-age Z-score (HAZ)
Time Frame: After 24 months of program implementation
In 6-59 months old children. To calculate HAZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Mean weight-for-height Z-score (WHZ)
Time Frame: After 24 months of program implementation
In 6-59 months old children.To calculate WHZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Mean weight-for-age Z-score (WAZ)
Time Frame: After 24 months of program implementation
In 6-59 months old children.To calculate WAZ scores the 2006 WHO growth reference will be used
After 24 months of program implementation
Mean mid-upper arm circumference (MUAC)
Time Frame: After 24 months of program implementation
In 6-59 months old children.
After 24 months of program implementation
Caregiver's knowledge related to breastfeeding, complementary feeding,child health and hygiene, the condition of severe acute malnutrition, outpatient therapeutic programs, screening of wasting
Time Frame: After 24 months of program implementation
Presented as a total standardized score and by knowledge domain
After 24 months of program implementation
Vaccination coverage
Time Frame: After 24 months of program implementation
Proportion of children aged 6-18 months with SAM or enrolled in SAM OTP who received all age-recommended immunizations
After 24 months of program implementation
Introduction of (semi) solid and soft complementary foods
Time Frame: After 24 months of program implementation
The proportion of children 6-8 months of age who consumed (semi) solid and soft complementary foods during the previous day
After 24 months of program implementation
Minimum dietary diversity in infants and young children (6-23 mo)
Time Frame: After 24 months of program implementation
The proportion of study children aged 6-23 months who consumed at least 5 of the 8 food groups (including breast milk) during the previous day
After 24 months of program implementation
Nr of food groups consumed by infants and young children (6-59 mo)
Time Frame: After 24 months of program implementation
The mean number of food groups consumed during the previous day by study children aged 6-59
After 24 months of program implementation
Minimum meal frequency in infants and young children
Time Frame: After 24 months of program implementation
Defined as the proportion of study children who had eaten during the previous day: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 monthsMinimum meal frequency for children, defined as the proportion of children who had eaten the day before the survey: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 months.
After 24 months of program implementation
Minimum acceptable diet in infants and young children
Time Frame: After 24 months of program implementation
Defined as the proportion of study children aged 6-23 months with both minimal dietary diversity and minimal meal frequency during the previous day
After 24 months of program implementation
Continuous breastfeeding 12-23 months
Time Frame: After 24 months of program implementation
Defined as the proportion of children aged 12-23 months breastfed during the previous day
After 24 months of program implementation
Egg and/or flesh food consumption
Time Frame: After 24 months of program implementation
Proportion of children 6-23 months of age who consumed egg and/or flesh food during the previous day
After 24 months of program implementation
Sweet beverage consumption
Time Frame: After 24 months of program implementation
Proportion of children 6-23 months of age who consumed a sweet beverage during the previous day
After 24 months of program implementation
Zero vegetable or fruit consumption consumption
Time Frame: After 24 months of program implementation
Proportion of children 6-23 months of age who did not consume any vegetables or fruits during the previous day
After 24 months of program implementation
Minimum milk feeding frequency for non-breastfed children
Time Frame: After 24 months of program implementation
Proportion of non-breastfed children 6-23 months of age who consumed at least two milk feeds during the previous day
After 24 months of program implementation
Weight-for-length Z-score and MUAC at Severe Acute Malnutrition (SAM) Outpatient Therapeutic Feeding program (OTP)
Time Frame: 24 months from baseline until endline of the study
Weight-for-length Z-score (relative to the 2006 WHO reference) and MUAC(mm)
24 months from baseline until endline of the study
SAM OTP adherence
Time Frame: 24 months from baseline until endline of the study
Defined as the proportion of cases enrolled to SAM OTP who received timely treatment from dedicated services (health center or health post) until anthropometric recovery
24 months from baseline until endline of the study
Weight gain rate during SAM OTP
Time Frame: 24 months from baseline until endline of the study
Defined as the weight gain during SAM OTP divided by the length of treatment and divided by the child's weight
24 months from baseline until endline of the study
SAM OTP outcomes (drop-out, death, transfer, non-response rates)
Time Frame: 24 months from baseline until endline of the study
Among cases admitted to SAM OTP
24 months from baseline until endline of the study
SAM OTP duration
Time Frame: 24 months from baseline until endline of the study
Defined as the number of days spent in SAM OTP (from admission to discharge)
24 months from baseline until endline of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lieven Huybregts, PhD, International Food Policy Research Institute
  • Principal Investigator: Tefera Belachew, PhD, Ethiopian Public Health Association

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2024

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

June 30, 2027

Study Registration Dates

First Submitted

April 18, 2024

First Submitted That Met QC Criteria

April 23, 2024

First Posted (Actual)

April 24, 2024

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 25, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wasting

Clinical Trials on R-SWITCH integrated intervention package

Subscribe